Patent Foramen Ovale Closure or Anticoagulation vs. Antiplatelets after Stroke
Volume: 377, Issue: 11, Pages: 1011 - 1021
Published: Sep 14, 2017
Abstract
Trials of patent foramen ovale (PFO) closure to prevent recurrent stroke have been inconclusive. We investigated whether patients with cryptogenic stroke and echocardiographic features representing risk of stroke would benefit from PFO closure or anticoagulation, as compared with antiplatelet...
Paper Details
Title
Patent Foramen Ovale Closure or Anticoagulation vs. Antiplatelets after Stroke
Published Date
Sep 14, 2017
Volume
377
Issue
11
Pages
1011 - 1021
Citation AnalysisPro
You’ll need to upgrade your plan to Pro
Looking to understand the true influence of a researcher’s work across journals & affiliations?
- Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
- Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.
Notes
History